Expression of measles virus antigens in Streptococcus gordonii

New Microbiologica

Volumn 23, Issue 2, 2000, Pages 119-128

  Maggi, T ^a   Oggioni, M R ^a   Medaglini, D ^a   Bianchi Bandinelli, M L ^a   Soldateschi, D ^b   Wiesmuller K H ^c   Muller, C P ^d   Valensin, P E ^a   Pozzi, G ^a  

^a UNIVERSITY OF SIENA   (Italy)

^b Diagnostica Senese   (Italy)

^c UNIVERSITY OF TÜBINGEN   (Germany)

^d NONE

Author keywords

Measles virus antigens; Measles virus vaccines; Recombinant vaccines; Streptococcus gordonii; Vaccine vectors

Indexed keywords

HEMAGGLUTININ PROTEIN G, MEASLES VIRUS; MEASLES VACCINE; RECOMBINANT PROTEIN; RECOMBINANT VACCINE; VIRUS ANTIGEN; VIRUS FUSION PROTEIN; VIRUS HEMAGGLUTININ;

ANIMAL; ANTIBODY SPECIFICITY; ARTICLE; BAGG ALBINO MOUSE; BIOSYNTHESIS; FEMALE; GENETICS; IMMUNOLOGY; MEASLES VIRUS; MOUSE; STREPTOCOCCUS;

ANIMALS; ANTIBODY SPECIFICITY; ANTIGENS, VIRAL; FEMALE; HEMAGGLUTININS, VIRAL; MEASLES VACCINE; MEASLES VIRUS; MICE; MICE, INBRED BALB C; RECOMBINANT PROTEINS; STREPTOCOCCUS; VACCINES, SYNTHETIC; VIRAL FUSION PROTEINS;

EID: 0034168257     PISSN: 11217138     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. (1997a). Gram-positive bacteria. Vaccine vehicles for mucosal immunization. Springer-Verlag Berlin and Landes Bioscience Georgetown.
2. (1997b). Progress towards global measles control and elimination. Morbidity and Mortality Weekly, 46, 893-897.
3. ALKHATIB, G., SHEN, S.H., BRIEDIS, D., RICHARDSON, C., MASSIE, B., WEINBERG, R., SMITH. D, TAYLOR, J., PAOLETTI, E., and RODER, J. (1994). Functional analysis of N-linked glycosylation mutants of the measles virus protein synthesized by recombinant vaccinia virus vectors. Journal of Virology, 68, 1522-1531.
4. ALKHATIB, G., and BRIEDIS, D. (1986). The predicted primary structure of the measles virus hemagglutinin. Virology, 150, 479-490.
5. AUSUBEL, F.M., BRENT, R., KINGSTON, R.E., MOORE, D.D., SEIDMAN, J.G., SMITH, J.A., and STRUHL, K. (1995). Current protocols in molecular biology. New York: John Wiley and Sons.
6. CHIRGWIN, J.M., PRZYBYLA, A.E., MAC DONALD, R.J., and RUTTER, W.J. (1979). Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry, 18, 5249-5299.
7. CHOPPIN, P.W., and SCHEID, A. (1980). The role of viral glycoproteins in adsorption, penetration, and pathogenicity of viruses. Review of Infectious Diseases, 2, 40-61.
8. DERES, K., SCHILD, H., WIESMULLER, K.H., JUNG, G., and RAMMENSEE, H.G. (1989). In vivo priming of virus-specific cytotoxic T lymphocytes with synthetic lipopeptide vaccine. Nature, 342, 561-564.
9. DRILLIEN, R., SPEHNER, D., KIRN, A., GIRAUDON, P., BUCKLAND, R., WILD, T.F., and LECOCQ, J.P. (1988). Protection of mice from fatal measles encephalitis by vaccination with vaccinia virus recombinants encoding either hemagglutinin or the fusion protein. Proceedings of the National Academy of Science USA, 85, 1252-1256.
10. FENNELLY, G.J., FLYNN, J.L., TER MEULEN, V., LIEBERT, U.G., and BLOOM, B.R. (1995). Recombinant bacille Calmette-Guerin priming against measles. The Journal of Infectious Diseases, 172, 698-705.
11. FOOKS, A.R., JEEVARAJAH, D., LEE, J., WARNES, A., NIEWIESK, S., TER MEULEN, V., STEPHENSON, J.R., and CLEGG, J.C. (1998). Oral or parental administration of replication-deficient adenoviruses expressing the measles virus haemagglutinin and fusion proteins: prospective immune responses in rodents. Journal General Virology, 79, 1027-1031.
12. FOOKS, A.R., JEEVARAJAH, D., WARNES, A., WILKINSON, G.W., and CLEGG, J.C. (1996). Immunization of mice with plasmid DNA expressing the measles virus nucleoprotein gene. Viral immunol, 9, 65-71.
13. HOLLINGSHEAD, S.K., FISCHETTI, V.A., and SCOTT, J.R. (1986). Complete nucleotide sequence of type 6 M protein of the group A streptococcus: repetitive structure and membrane anchor. The Journal of Biological Chemistry, 261, 1677-1686.
14. LAMBERT, P.H. (1994). Research priorities for vaccines to be used at a global level. Behring Inst Mitt, 95, 1-6.
15. MEDAGLINI, D., RICCI, S., MAGGI, T., RUSH, C.M., MANGANELLI, R., OGGIONI, M.R., and POZZI, G. (1997). Recombinant Gram-positive bacteria as vehicles of vaccine antigens. Biotechnology Annual Review, 3, 297-312.
16. MEDAGLINI, D., OGGIONI, M.R., and POZZI, G. (1998). Vaginal immunization with recombinant Gram positive bacteria. American Journal of Reproductive Immunology, 39, 199-208.
17. MEDAGLINI, D., POZZI, G., KING, T.P., and FISCHETTI, V.A. (1995). Mucosal and systemic immune responses to a recombinant protein expressed on the surface of the oral commensal bacterium Streptococcus gordonii after oral colonization. Proceedings of the National Academy of Science USA, 92, 6868-6872.
18. MEDAGLINI, D., RUSH, C.M., SESTINI, P., and POZZI, G. (1997). Commensal bacteria as vehicles for mucosal vaccines against sexually transmitted diseases: vaginal colonisation with recombinant streptococci includes local and systemic antibodies in mice. Vaccine, 15, 1330-1337.
19. MULLER, C.P., SCHROEDER, T., TU, R., BRONS, N.H., JUNG, G., SCHNEIDER, F., and WIESMULLER, K.H. (1993). Analysis of the neutralizing antibody response to the measles virus using synthetic peptides of the haemagglutinin protein. Scand Immunol, 38, 463-471.
20. OGGIONI, M.R., MEDAGLINI, D., ROMANO, L., PERUZZI, F., MAGGI, T., LOZZI, L., BRACCI, L., ZAZZI, M., MANCA, F., VALENSIN, P.E., and POZZI, G. (1999). Antigenicity and immunogenicity of the V3 domain of HIV-1 gp120 expression on the surface of Streptococcus gordonii. AIDS Research and Human Retroviruses, 15, 451-459.
21. OGGIONI, M.R., MANGANELLI, R., CONTORNI, M., TOMMASINO, M., and POZZI, G. (1995). Immunization of mice by oral colonization with live recombinant commensal streptococci. Vaccine, 13, 775-779.
22. OGGIONI, M.R., and POZZI, G. (1996). A host-vector system for heterologous gene expression in Streptococcus gordonii. Gene, 169, 85-90.
23. POZZI, G., CONTORNI, M., OGGIONI, M.R., MANGANELLI, R., TOMMASINO, M., CAVALIERI, F., and FISCHETTI, V.A. (1992). Delivery and expression of a heterologous antigen on the surface of streptococci. Infection and Immunity, 60, 1902-1907.
24. POZZI, G., OGGIONI, M.R., MANGANELLI, R., MEDAGLINI, D., FISCHETTI, V.A., FENOGLIO, D., VALLE, M.T., KUNKL, A., and MANCA, F. (1994). Human T-helper cell recognition of an immunodominant epitope of HIV-1 gp120 expressed on the surface of Streptococcus gordonii. Vaccine, 12, 1071-1077.
25. POZZI, G., MUSMANNO, R.A., LIEVENS, P.M.J., OGGIONI, M.R., PLEVANI, P., and MANGANELLI, R. (1990). Method and parameters for genetic transformation of Streptococcus sanguis Challis. Research in Microbiology, 141, 659-670.
26. POZZI, G., OGGIONI, M.R., MANGANELLI, R., and FISCHETTI, V.A. (1992). Expression of M6 protein gene of Streptococcus pyogenes in Streptococcus gordonii after chromosomal integration and transcriptional fusion. Research in Microbiology, 143, 449-459.
27. POZZI, G., OGGIONI, M.R., and MEDAGLINI, D. (1997). Recombinant Streptococcus gordonii as live vehicle for vaccine antigens. In G. Pozzi & J.M. Wells (Eds.), Gram-positive bacteria. Vaccine vehicles for mucosal immunization. (pp. 35-60). Springer-Verlag Berlin and Landes Bioscience Georgetown.
28. RESCIGNO, M., CITTERIO, S., THERY, C., RITTIG, M., MEDAGLINI, D., POZZI, G., AMIGORENA, S., and RICCIARDI-CASTAGNOLI, P. (1998). Bacterial-induced neo-biosynthesis, stabilization and surface expression of functional class I molecules in mouse dendritic cells. Proceedings of the National Academy of Science USA, 95, 5229-5234.
29. RICHARDSON, C., HULL, D., GREER, P., HASEL, K., BERKOVICH, A., ENGLUND, G., BELLINI, W.J., RIMA, B., and LAZZARINI, R. (1986). The nucleotide sequence of the mRNA encoding the fusion protein of measles virus (Edmonston strain): a comparison of fusion proteins from several different paramyxoviruses. Virology, 155, 508-523.
30. SAMBROOK, J., FRITSCH, E.F., and MANIATIS, T. (1989). Molecular Cloning. Cold Spring Harbor, New York: Cold Spring Harbor Laboratory Press.
31. SANGER, F., NICKLEN, S., and COULSON, A.R. (1977). DNA sequencing with chain-terminating inhibitors. Proceedings of the National Academy of Science USA, 74, 5463-5467.
32. SCHODEL, F., and WILL, H. (1989). Construction of a plasmid for expression of foreign epitopes as fusion proteins with subunit B of Escherichia coli heat-labile toxin. Infection and Immunity, 57, 1347-1350.
33. STAHL, S., and UHLEN, M. (1997). Bacterial surface display: trends and progress. Trends in Biotechnology, 15, 185-192.
34. VERJANS, G.M., JANSSEN, R., UYTDEHAAG, F.G., VAN DOORNIK, C.E., and TOMMASSEN, J. (1995). Intracellular processing and presentation of T cell epitopes, expressed by recombinant Escherichia coli and Salmonella typhimurium, to human T cells. Eur. J. Immunol, 25, 405-410.
35. ZHU, Y.D., FENNELLY, G., MILLER, C., TARARA, R., SAXE, I., BLOOM, B., and MCCHESNEY, M. (1997). Recombinant bacille Calmette-Guerin expressing the measles virus nucleoprotein protects infant rhesus macaques from measles virus pneumonia. The Journal of Infectious Diseases, 176, 1445-1453.